All Stories

  1. Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model

    Article • European Heart Journal, July 2017, Oxford University Press (OUP)

    Dr Ashish Mehta, Professor Peter J Schwartz